Literature DB >> 3463863

Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.

J J DiGiovanna, R K Helfgott, L H Gerber, G L Peck.   

Abstract

Isotretinoin, a synthetic retinoid that has been prescribed for over 500,000 patients with cystic acne, has been associated with both spinal hyperostosis and a disorder similar to diffuse idiopathic skeletal hyperostosis. We describe a syndrome of tendon and ligament calcification, primarily in extraspinal locations, that we have observed after long-term therapy for psoriasis and disorders of keratinization with etretinate, another synthetic retinoid. Of 38 patients who had received etretinate (average dose, 0.8 mg per kilogram of body weight per day; average duration, 60 months), 32 (84 percent) had radiographic evidence of extraspinal tendon and ligament calcification. The most common sites of involvement were the ankles (29 patients [76 percent]), pelvis (20 patients [53 percent]), and knees (16 patients [42 percent]); spine involvement was uncommon in this group of etretinate-treated patients. Involvement tended to be bilateral and multifocal. Fifteen (47 percent) of the 32 affected patients had no bone or joint symptoms at the sites of radiographic abnormality. Thus, tendon and ligament calcification can occur without vertebral involvement as well as in association with it (for example, as part of the spectrum of diffuse idiopathic skeletal hyperostosis). We have identified extraspinal tendon and ligament calcification as a toxic effect that is commonly associated with long-term etretinate therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463863     DOI: 10.1056/NEJM198611063151901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

1.  Case report: psoriatic erythroderma with bilateral osseous bridge across the acetabulum.

Authors:  Shigeyoshi Tsuji; Tetsuya Tomita; Masahiro Inaoka; Mari Higashiyama
Journal:  Clin Orthop Relat Res       Date:  2009-08-06       Impact factor: 4.176

Review 2.  Indinavir-induced retinoid-like effects: incidence, clinical features and management.

Authors:  Jesús García-Silva; Manuel Almagro; Carmen Peña-Penabad; Eduardo Fonseca
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Diffuse idiopathic skeletal hyperostosis (DISH) - A common but less known cause of back pain.

Authors:  Raju Vaishya; Vipul Vijay; Ifeanyi Charles Nwagbara; Amit K Agarwal
Journal:  J Clin Orthop Trauma       Date:  2016-12-02

4.  Diffuse idiopathic skeletal hyperostosis (DISH) of the shoulder. A controlled radiological study.

Authors:  C Beyeler; T Lehmann; P Schlapbach; N J Gerber; W A Fuchs
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 5.  Adverse effects of retinoids.

Authors:  M David; E Hodak; N J Lowe
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

Review 6.  Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.

Authors:  F G Larsen; F Nielsen-Kudsk; P Jakobsen; K Weismann; K Kragballe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

7.  Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.

Authors:  A A Gaspari; T A Fleisher; K H Kraemer
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 8.  Hormones and growth factors in the pathogenesis of spinal ligament ossification.

Authors:  Hai Li; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Eur Spine J       Date:  2007-04-11       Impact factor: 3.134

9.  Acitretin : A Review of its Pharmacology and Therapeutic Use.

Authors:  Tania Pilkington; Rex N Brogden
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

10.  Diffuse idiopathic skeletal hyperostosis: A review.

Authors:  Fábio A Nascimento; Luana Antunes Maranha Gatto; Roberto Oliver Lages; Heraldo Mello Neto; Zeferino Demartini; Gelson Luis Koppe
Journal:  Surg Neurol Int       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.